IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lamond Capital Partners LLC

Q3 2015 Holdings

Filed 2015-11-09 | 10 holdings | $10.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$10.5M100,00098.8%
Amgen Inc(AMGN)CallCOM031162100$20.7K150,0000.2%
Oracle Corp(ORCL)CallCOM68389X105$18.1K500,0000.2%
Ocular Therapeutix Inc(OCUL)COM67576A100$17.3K1,233,2850.2%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$15.6K100,0000.1%
Amgen Inc(AMGN)COM031162100$13.8K100,0000.1%
Abbvie Inc(ABBV)CallCOM00287Y109$13.6K250,0000.1%
GW Pharmaceuticals PLCADS36197T103$11.0K120,0000.1%
Cypress Semiconductor Corp(CYEUR)COM232806109$9.4K1,100,0000.1%
Kite Pharma IncCallCOM49803L109$3.5K63,4000.0%